Controversial issues in the treatment of hyperkalaemia

Nephrology Dialysis Transplantation

Volumn 18, Issue 11, 2003, Pages 2215-2218

  Kamel, Kamel S ^a   Wei, Charles ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b LAKERIDGE HEALTH CORPORATION   (Canada)

Author keywords

2 adrenergic agents; Cation exchange resins; Hyperkalaemia; Insulin; Sodium bicarbonate; Treatment

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BICARBONATE; CATION EXCHANGE RESIN; GLUCOSE; INSULIN; LAXATIVE; PHENOLPHTHALEIN; POLYSTYRENESULFONATE CALCIUM; POLYSTYRENESULFONATE SODIUM; POTASSIUM; SALBUTAMOL; SODIUM PROTON EXCHANGE PROTEIN; SODIUM SULFATE; SORBITOL;

CALCIUM BLOOD LEVEL; CARDIOVASCULAR DISEASE; DIARRHEA; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; EDITORIAL; EMERGENCY TREATMENT; EXTRACELLULAR FLUID; HEART ARRHYTHMIA; HEMODIALYSIS; HUMAN; HYPERCAPNIA; HYPERKALEMIA; HYPERNATREMIA; HYPOCALCEMIA; HYPOGLYCEMIA; KIDNEY FAILURE; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; PRIORITY JOURNAL;

ADRENERGIC BETA-AGONISTS; CATION EXCHANGE RESINS; HUMANS; HYPERKALEMIA; HYPOGLYCEMIC AGENTS; INSULIN; SODIUM BICARBONATE;

EID: 0242320332     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg323     Document Type: Editorial

References (28)

1. Weiner DI, Wingo CS. Hyperkalemia: a potential silent killer. J Am Soc Nephrol 1998; 9: 1535-1543
2. Iqbal Z, Friedman EA. Preferred therapy of hyperkalemia in renal insufficiency: survey of nephrology training-program directors. N Engl J Med 1989: 320: 60-61
3. Blumberg A, Weidmann P, Shaw S et al. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 1988; 85: 507-512
4. Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 1990; 38: 869-872
5. Allon M, Shanklin N. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis 1996; 28: 508-514
6. Lens XM, Montoliu J, Cases A, Campisotol JM, Rever L. Treatment of hyperkalemia in renal failure: salbutamol v. insulin. Nephrol Dial Transplant 1989; 4: 228-232
7. Kim HJ. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 1996; 72: 476-482
8. Conte G, Dal Canton A, Imperatore P et al. Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure. Kidney Int 1990; 38: 301-307
9. Montoliu J, Lens XM, Revert L. Potassium-lowering effect of albuterol for hyperkalemia in renal failure. Arch Intern Med 1987; 147: 713-717
10. Liou HH, Chiang SS, Wu SC et al. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure. Am J Kidney Dis 1994; 23: 266-270
11. Kemper MJ, Harps E, Muller-Wiefel DE. Hyperkalemia: therapeutic options in acute and chronic renal failure. Clin Nephrol 1995; 46: 67-69
12. Allon M, Dunlay R, Copkney C. Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 1989; 110: 426-429
13. Montoliu J, Almirall J, Ponz E et al. Treatment of hyperkalemia in renal failure with salbutamol inhalation. J Intern Med 1990; 228: 35-37
14. Mandelberg A, Krupnik Z, Houri S. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? how safe? Chest 1999; 115: 617-622
15. Halperin ML, Kamel KS. Potassium. Lancet 1998; 352: 135-142
16. Blumberg A, Weidmann P, Ferrari P. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int 1992; 41: 369-374
17. Guttierez R, Schlessinger F, Oster JR et al. Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end-stage renal disease. Miner Electrolyte Metab 1991; 17: 297-302
18. Schwarz KC, Cohen BD, Lubash GD et al. Severe acidosis and hyperpotassemia treated with sodium bicarbonate infusion. Circulation 1959; 19: 215-220
19. Emmett M, Hootkins RE, Fine KD. Effect of three laxatives and a cation exchange resin on fecal sodium and potassium excretion. Gastroenterology 1995; 108: 752-760
20. Johnson LR. Fluid and electrolyte absorption. In: Johnson LR, ed. Gastrointestinal Physiology. Mosby-Yearbook, Philadelphia, PA: 1997; 135-145
21. Binder HJ, Sandle GI. Electrolyte absorption and secretion in mammalian colon. In: Johnson RL, ed. Physiology of the Gastrointestinal Tract. Raven Press, New York, NY: 1987; 1389-1418
22. Kanaghinis T, Lubran M, Coghil NF. The composition of ileostomy fluid. Gut 1963; 4: 322-338
23. Sandle GI, Gaiger E, Tapster S, Goodship THJ. Evidence for large intestinal control of potassium homeostasis in uremic patients undergoing long term dialysis. Clin Sci 1987; 73; 247-252
24. Martin RS, Panese S, Virginillo M et al. Increased secretion of potassium in the rectum of humans with chronic renal failure. Am J Kidney Dis 1988; 8: 105-110
25. Agarwal R, Afzalpurkar R, Fordtran J. Pathophysiology of potassium absorption and secretion by the human intestine. Gastroenterology 1994; 107: 548-571
26. Flinn RB, Merrill JP, Welzant WR. Treatment of the oliguric patient with a new sodium-exchange resin and sorbitol. N Engl J Med 1961; 264: 111-115
27. Scherr L, Ogden DA, Mead AW. Management of hyperkalemia with a cation-exchange resin. N Engl J Med 1961; 264: 115-119
28. Gruy-Kapral C, Emmett M, Santa Ana CA. Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease. J Am Soc Nephrol 1998; 9: 1924-1930